Drugs & Targets European Commission authorizes Jemperli plus chemo in endometrial cancer indication January 05, 2024Vol.50 No.01
Drugs & Targets Infinimmune, Grid Therapeutics form partnership for deep sequencing of B cells for NSCLC drug discovery January 05, 2024Vol.50 No.01
Drugs & Targets FDA approves Iwilfin for adult and pediatric patients with high-risk neuroblastoma December 15, 2023Vol.49 No.46
Drugs & Targets AnHeart, Foundation Medicine form collaboration focused on NSCLC diagnostic December 15, 2023Vol.49 No.46
Drugs & Targets Fuse Oncology, University of Michigan form radiation oncology collaboration December 15, 2023Vol.49 No.46
Drugs & Targets FDA grants Fast Track designation to Alpha1H for non-muscle invasive bladder cancer December 08, 2023Vol.49 No.45
Drugs & Targets FDA approves Xtandi for non-metastatic castration-sensitive prostate cancer with biochemical recurrence December 01, 2023Vol.49 No.44
